BioSpace16h
The Making of BMS’ Cobenfy: From Alzheimer’s to Schizophrenia
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
'It raises hope': A new drug for schizophrenia approved for the first time in 70 years
The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...
Sydney Morning Herald12h
The Australian research (and brains) that led to a new schizophrenia drug
US researchers at pharmaceutical company Eli Lilly were investigating the drug xanomeline – which activates muscarinic ...
The New York Times11h
New York Times - Top Stories
The attack, which ended shortly after it began, capped a chaotic 24-hour period that began with Israel’s invading of Lebanon in pursuit of Hezbollah. Iran fired a barrage of ballistic missiles ...